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Mycobacterium tuberculosis remains one of the most pernicious of human pathogens. Current vaccines are
ineffective, and drugs, although efficacious, require prolonged treatment with constant medical oversight.
Overcoming these problems requires a greater appreciation of M. tuberculosis in the context of its host.
Upon infection of either macrophages in culture or animal models, the bacterium realigns its metabolism
in response to the new environments it encounters. Understanding these environments, and the stresses
that they place on M. tuberculosis, should provide insights invaluable for the development of new chemo-
and immunotherapeutic strategies.Introduction
Mycobacterium tuberculosis (Mtb) remains an enduring path-
ogen of mankind. Despite numerous ‘‘eradication’’ programs
over the past century, its penetrance remains at approximately
one-third of the human population, of which between 5% and
15% will develop active disease during the course of their life-
time. The success of this pathogen lies in its ability to maintain
the infection throughout the life of the human host, ready to reac-
tivate without apparent cause in immunocompetent individuals,
or in response to immune suppression in HIV patients or other
immunocompromised individuals. The ability of Mtb to infect
many of the individuals in a population yet only cause active
disease in a few likely aided the persistence of the pathogen
throughout human evolution, where, until recently, mankind
existed as isolated groups of individuals. Infectious agents with
more acute disease profiles run the risk of eradicating their
host population, unless they have animal reservoirs, which Mtb
lacks.
As a persistent pathogen, Mtb exhibits many characteristics
shared by other infectious agents capable of sustained infec-
tions. First, the stable or chronic infection state of such patho-
gens is usually maintained by a relatively low, and relatively
constant, parasite load. Second, because of the enduring nature
of this infection, these pathogens must either avoid the induction
of an acquired immune response, or subvert its consequences at
the localized level of the infection.
Early in infection tuberculosis follows a relatively reproducible
course. It is inferred that the first infected cell is the alveolar
macrophage that internalizes the bacilli following inhalation of
droplets aerosolized by individuals with active TB (Leemans
et al., 2001; Wolf et al., 2007). The infected macrophage invades
the subtending epithelium, and the resultant proinflammatory
response leads to recruitment of monocytes from the blood-
stream. This early, innate granulomatous response is sustained
primarily by phagocytes such as macrophages, monocytes,
and neutrophils (Tsai et al., 2006; Wolf et al., 2007). Analysis of
murine lungs during this early phase of infection has demon-
strated that the bacteria are retained almost exclusively within
phagocytes. Once an acquired immune response develops,
the granuloma becomes a stratified lesion with macrophages,68 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.giant cells, and foamy macrophages in the center, surrounded
by the lymphocyte-rich marginal zone (Flynn and Chan, 2005;
Russell, 2007; Russell et al., 2009a; Ulrichs and Kaufmann,
2006). In many lesions these cell populations are separated by
a fibrous layer of extracellular matrix (see Figure 1). In an infected
individual, even one with active disease, granulomas exist in all
states of development, from sterility, to containment, to cavita-
tion and release of infectious bacilli. This implies that, in immuno-
competent individuals at least, the ‘‘decisions’’ that culminate in
progression to active disease are determined locally, at the level
of each individual granuloma.
Several decades of histological observations from in vivo
infections in humans and animal models have documented
that the macrophage is the predominant host cell for much of
the infection cycle prior to the release of bacteria into the cavi-
tating lesion. Therefore, understanding the basis of survival of
Mtb within this phagocyte remains one of the key questions in
appreciating why this pathogen has been so successful. The
macrophage is known to be the primary defense mechanism
against microbial invasion (Deretic et al., 2009; Liu and Modlin,
2008; Nathan and Shiloh, 2000). It has a phagocytic system
that delivers the microbe into a compartment that is the site of
generation of reactive oxygen intermediate, increasing acidity,
hydrolytic activity, and the presence of antimicrobial peptides.
All of these killing pathways are impacted by the immune status
of the host macrophage, and activation with cytokines such as
interferon-g leads to control of the intracellular infection (Cooper
et al., 1993; North and Jung, 2004). It is within the context of this
environment that anti-Mtb drugs or vaccines need to function,
therefore appreciating the pressure points ofmacrophage-medi-
ated stress, and the Mtb responses, are critical to both under-
standing the biochemical basis of Mtb’s survival and the devel-
opment of novel intervention strategies.
Biology of the Phagosome
The macrophage forms a phagosome around any particle that
has ligated receptors capable of triggering internalization.
Studies on phagosomes containing inert particles such as
IgG-opsonized beads have developed a comprehensive under-
standing of the physiological changes active within the lumen
Figure 1. The Main Features of the Human
TB Granuloma
A fully formed human TB granuloma is an
extremely stratified structure. The center of the
granuloma is caseous in nature and rich in lipids,
thought to be derived from the lipids present in
foamy macrophages. The caseum is surrounded
by a macrophage-rich layer that contains foamy
macrophages, multinucleate giant cells, and epi-
thelioid macrophages. Mtb bacilli are observed in
many of these cells. This structure is frequently
encased in a fibrous capsule of collagen and other
extracellular matrix proteins. Lymphocytes tend to
be restricted to the periphery of the granuloma
outside the fibrous outer layer.
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derVen et al., 2009; Yates et al., 2005, 2007; Yates and Russell,
2005). The phagosome acidifies to below pH 5.0 within 10–12
min and reaches equilibrium with lysosomal content within 90
min postinternalization. This transition is marked by increasing
hydrolytic activities such as proteolysis, lipolysis, and nucleo-
tidase activity. In addition, ligation of certain phagocytic
receptors, such as the Fc receptor, will trigger generation of
superoxide in both resting and activated macrophages. The
superoxide burst is transient, enduring for 10–15 min postrecep-
tor ligation, and is enhanced in intensity, but not duration,
through activation by TLR agonists or IFN-g (VanderVen et al.,
2009). The phagosome possesses an impressive armamen-
tarium that has to be avoided, negotiated, or suppressed by
any aspiring intramacrophage pathogen.
Mtb’s primary mode of operation is one of avoidance. Once
inside the phagocytic compartment, the normal progression of
the phagosome is arrested prior to the acquisition of bactericidal
characteristics (see Figure 2). The pH of the Mtb-containing
phagosome is 6.4 (Sturgill-Koszycki et al., 1994). Certainly this
is more acidic than the extracellular milieu, but it is considerably
higher than that of a terminal lysosome, pH 4.5–5.0 (Yates et al.,
2005). Numerous bacterial moieties have been implicated in this
process from cell wall glycolipids (Axelrod et al., 2008; Katti et al.,
2008; Robinson et al., 2007; Vergne et al., 2003) to secreted
proteins (Vergne et al., 2005; Walburger et al., 2004), of which
the latter have been proposed to access the host cell cytosol.
Comparisons between the Mtb phagosome and inert particle-
containing phagosomes allow one to make certain predictions
about the physiological status of the phagosome lumen (Russell
et al., 2005). In an IgG-bead phagosome at pH 6.4 there is
minimal measurable proteolytic activity, and minimal mixing
with lysosomal cargo, suggesting acquisition of lysosomal anti-
microbial peptides will be low. Intriguingly, lipolytic activity is
high in early phagosomes, which presumably is required for
the processing of LDL particles that cycle through the early
endosomal compartment (Heeren et al., 2001; Sugii et al.,
2003). This lipolytic activity is mediated by lipoprotein lipase
(LPL) and other hepatic lipase family members. Given the shift
to lipid catabolism exhibited by intracellular Mtb, this activityCell Host & Micromight have special significance for the
physiology of this compartment. Recent
whole-cell-based screens for lipase
inhibitors have identified novel inhibitorsof these activities and acid lipase activity, which may provide
fresh insights into the importance of this host-cell-derived
activity to bacterial survival (VanderVen et al., 2010).
Activation of the host macrophage by either TLR agonists or
IFN-g leads to alterations in the Mtb-containing phagosome
that impact negatively on the bacterium’s capacity to replicate
and/or survive (MacMicking et al., 2003; Schaible et al., 1998;
Via et al., 1998). The primary killing mechanism in activated
macrophages is through the production of reactive nitrogen
intermediates generated by the activity of the inducible nitric
oxide synthase (MacMicking et al., 1997). NO-mediated killing,
however, functions in tandem with other activities such as the
increased acidification of the phagosome (to pH 5.2), which halts
bacterial replication, and exposure to lysosomal hydrolases and
antibacterial peptides in the macrophage lysosome (Alonso
et al., 2007; Gutierrez et al., 2004). These activation states are
not binary, and host phagocytes are likely to exist across a broad
spectrum of activation states that are linked to their location
within granulomas. The heterogeneity in both pathogen and
host renders interpretation of data from population-based
studies such as transcriptome analysis or genome-wide genetic
screens difficult to interpret without extensive underpinning from
in vitro infection models.
In addition to intraphagosomal survival, investigators also
report that Mtb, along with other mycobacterial spp., are capa-
ble of escaping the phagosome and accessing the cytoplasm
(van der Wel et al., 2007). While the data that this occurs in
some intracellular infection models are compelling (Hagedorn
et al., 2009; van der Wel et al., 2007), the majority of studies on
intracellular survival of Mtb in murine macrophages do not
observe cytosolic bacteria. It is likely, therefore, that escape
from the vacuole is not a requirement for bacteria survival and
growth. However, the possibility that Mtb has an albeit transient
cytosolic location during infection has major implications for
nutrient utilization, and the possible significance of a cytosolic
phase in vivo needs to be examined in greater depth.
Mtb’s Response to the Intracellular Environment
Despite the fact that Mtb arrests maturation of its phagosome
prior to fusion with lysosomes, the intracellular environment isbe 8, July 22, 2010 ª2010 Elsevier Inc. 69
Figure 2. Diagram of the Mtb-Containing Phagosome
Mtb resides in a phagosome that is arrested at the early endosomal stage of
maturation and fails to fuse with mature lysosomes. The pH of the vacuole is
pH 6.4, and the compartment remains fusigenic and continues to mix with
the recycling endosomal system (Clemens and Horwitz, 1996; Sturgill-
Koszycki et al., 1994, 1996). Endosomal cargo, such as transferrin, can be
visualized passing through the Mtb-containing vacuole. The trafficking of
LDL bound to the LDL receptor mirrors that of transferrin. LDL is likely pro-
cessed by the LPL in the early endosome (Heeren et al., 2001), which could
render the cholesterol core accessible to the bacterium. In the host cell,
cholesterol is transported into the cytosol and complexed with cholesterol-
binding proteins prior to its esterification and incorporation into lipid droplets
within the leaflets of the ERmembrane. At later stages in foamy macrophages,
Mtb has been observed within the lipid droplets in the cells, indicating that
there can be direct communication between the Mtb-containing vacuole and
the droplets (Peyron et al., 2008). This association is consistent with genetic
evidence indicating that Mtb exploits cholesterol as a carbon source during
infection (Pandey and Sassetti, 2008).
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bacterium in rich culture medium. This environmental transition
has been probed by several groups exploiting genome-wide
microarray analysis of the bacterial transcriptome. The original
study by Schnappinger and colleagues detailed transcriptional
responses consistent with the intracellular environment being
limited in nutrients and exerting considerable oxidative and nitro-
sative stress, particularly in activated macrophages (Schnap-
pinger et al., 2003). In addition, they noted upregulation of genes
in the DosR regulon, which can respond to a range of stresses
such as nitric oxide, carbonmonoxide, low pH, and SDS (Rustad
et al., 2009). The study also reported the upregulated expression
of genes involved in lipid metabolism, consistent with earlier
studies demonstrating that perturbation of carbon flow from lipid
metabolism reduces the virulence of intracellular Mtb (McKinney
et al., 2000).
A more recent study focusing on the initial response of Mtb to
transition into the phagosome identified a smaller set of genes
(68 genes) whose expression was upregulated 2 hr postinfection70 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.in murine macrophages (Rohde et al., 2007). When the ability of
the macrophage to acidify its phagosome was blocked pharma-
cologically with the proton ATPase inhibitor concanamycin A
(Cca), a subset of 24 genes was no longer upregulated. This indi-
cates that, although the Mtb-containing phagosome does not
fuse with lysosomes, the pH drop from pH 7.0 in the external
medium to pH 6.4 in the Mtb vacuole constitutes a dominant
environmental signal that shapes the transcriptional response
of the bacterium. Mtb expresses a PhoP homolog (Buchmeier
et al., 2000), and PhoP has been demonstrated to be the major
pH sensor in intracellular bacteria such as Salmonella (Martin-
Orozco et al., 2006). Interestingly, many of the 24 Cca-sensitive,
pH-regulated genes have also been shown to be regulated
by PhoP (Walters et al., 2006). Mtb mutants defective in PhoP
demonstrate a marked drop in virulence in the murine model.
Although this phenotype may be driven by the loss of viru-
lence-associated methyl-branched lipids or the absence of
ESAT6/CFP10 secretion in the PhoP mutant, it is also consistent
with pH sensing playing an important role in adapting to an intra-
cellular existence (Frigui et al., 2008; Ludwiczak et al., 2002;
Perez et al., 2001).
Several groups have now performed array analysis of the Mtb
transcriptome in infection models and, while broad themes are
conserved and reproduced faithfully, there is considerable vari-
ation between the data sets. These variations are likely due to
bacterial strains, and culture and experimental conditions;
however, they do limit the reliability of the data sets for identifica-
tion of candidate genes key to survival. To address this issue,
and to establish a ‘‘core’’ intracellular transcriptome, we exam-
ined the transcriptional profile of 15 recent clinical isolates that
provide representation across the genetically distinct strains of
the Mtb complex that span the globe, which includes M. tuber-
culosis and the closely related African species such asM. africa-
num (Homolka et al., 2010). Analysis of the transcriptional
profiles of these clinical isolates both in broth culture and 24 hr
postinfection in murine macrophages demonstrated the fol-
lowing points. First, condition-tree analysis of the transcriptional
profiles segregated according to genotype, indicating that the
genetic variation translated into functional diversity across these
strains. This is consistent with the emerging realization that the
Mtb complex is more heterogeneous than appreciated previ-
ously. Second, from all of these strains we were able to define
a universal, or ‘‘core’’ transcriptome induced by the intracellular
environment (Figure 3). This transcriptome consists of 280 genes
with 168 genes induced and 112 genes repressed in all isolates
examined. The transcriptome reflects exposure to host-medi-
ated stress with increased expression of genes connected with
hypoxia, radical stress, cell wall remodeling, and lipid metabo-
lism. This response was emphasized further in Mtb from acti-
vated macrophages, which also exhibited a strong downregula-
tion of expression of genes linked to bacterial growth, such as
ribosomal subunits. The ubiquitous expression and conserved
regulation of these genes across this diverse panel of clinical
strains form a powerful argument for prioritization of drug targets
or vaccine candidates. Finally, while all these intramacrophage
studies have been extremely informative, the infection of the
macrophage in culture does not reflect all of the environments
that the bacterium will encounter in the tissues of its human
host.
Figure 3. Venn Diagram of the Universally Expressed Transcriptome
The Venn diagrams illustrate those genes with conserved expression and
regulation inside macrophage across the panel of MTC clinical isolates. The
gene expression profiles of 17 MTC strains 24 hr postinfection of resting
macrophages and macrophages activated overnight with interferon-g were
determined by microarray. Normalized expression ratios for each strain were
determined by comparison of RNA from intracellular bacteria versus control
bacteria of the same strain in medium (Homolka et al., 2010). This enabled
the delineation of the macrophage-specific response for each individual
isolate. The Venn diagrams illustrate the activation-dependent (magenta)
and independent (green) genes, together with those genes up or downregu-
lated independent of macrophage status across clinical isolates (merged).
Genes in the core transcriptome were selected based on trending up or
down in all strains (up or down >1.2-fold in 15 of 17 strains).
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Once the infection has established itself in its host, the growth
pattern across the bacterial population appears relatively con-
served in animal models. There is a period of rapid replication
until the host develops an acquired immune response, and at
that time the granuloma adopts a more stratified structure with
a lymphocytic cuff. At this stage in the infection the bacterial
population stabilizes and remains constant within the lung (North
and Jung, 2004). At this point there are no overt signs of disease
and the infection is under immune-mediated control. When
analyzed at the gross level, the constant bacterial load implies
reduced growth; however, attempts to determine whether or
not this represents a static population or overlapping curves
of replication and death have produced mixed results. Earlier
experiments attempting to detect accumulation of cell wall
debris by electron microscopy (Rees and Hart, 1961), or the
rigorous quantitation of genome equivalents (Munoz-Elias
et al., 2005), indicated that the bulk of the bacterial population
was nonreplicating. However, more recent use of an unstable
‘‘clock’’ plasmid, which is lost at a predictable rate during bacte-
rial division, has generated some intriguing new insights into the
bacteria population in vivo (Gill et al., 2009). Data from this latter
study indicate that colony-forming unit counts underestimate
the bacterial population by approximately one log and that
the bacteria continue to replicate throughout the duration of the
experimental infection (111 days). The authors argue that the
population remains dynamic and that altered rates of killing
rather than replication are the primary factor that determines
the overall bacterial burden. However, all three studies were per-
formed in mice, which do not generate the structured granu-
lomas observed in human infection; therefore, while this is an
important observation we still need to determine the metabolic
state of Mtb required to sustain a chronic infection in the real
host, humans.
Hypoxia has long been considered as the dominant environ-
mental condition that regulates bacterial growth during thechronic phase of infection (Deb et al., 2009; Wayne and Sohas-
key, 2001). Models involving controlled reduction of oxygen in
in vitro culture conditions establish a nonreplicative state from
which Mtb recovers vigorously. The use of the hypoxia indicator
Pimonidazole in humans, coupled to the direct measurements of
oxygen tension in granulomas from primates and rabbits, has
confirmed the belief that advanced granulomas, with the loss
of vasculature, represent a microaerophilic environment (Via
et al., 2008). When Mtb is exposed to a low O2 environment, it
upregulates genes that are controlled, at least initially, by the
dosS-, dosT-, and dosR-encoded regulator complex (Boon
and Dick, 2002; Park et al., 2003). The DosR regulon comprises
approximately 48 early response genes that support survival of
the bacilli in an anaerobically induced state of ‘‘dormancy,’’ shift
the bacteria’s metabolism from aerobic to anaerobic, and
support exit of Mtb from the dormant state into one of active
replication (Leistikow et al., 2009; Rustad et al., 2009). However,
in infection studies performed on mice, guinea pigs, and rabbits,
mutants of Mtb that were defective in dosR revealed only
a minimal phenotype (Converse et al., 2009). This calls into
question either the hypoxic state in the in vivo infection or the
suitability of these animal models for reproducing the low-
oxygen environment found in the TB granulomas of higher
primates.
Realignment of Mtb Metabolism Inside the Host
The shift in metabolism exhibited by Mtb in the host has been
revealed by the loss of virulence of bacteria defective in different
genes important for lipid metabolism (Brzostek et al., 2007;
Chang et al., 2009; McKinney et al., 2000; Movahedzadeh
et al., 2004; Nesbitt et al., 2010), and by alterations in the cell
wall lipids that the bacterium expresses in liquid culture versus
in infection models (Gonzalo Asensio et al., 2006; Reed et al.,
2007; Singh et al., 2009; Walters et al., 2006). This is likely
preserved in in vivo infections where it has been reported that
Mtb lose their acid-fastness and become difficult to detect
(Ulrichs and Kaufmann, 2006). The full significance of these alter-
ations in lipid metabolism has yet to be revealed; however, there
are several observations that are coming together to identify the
issues facingMtb when exploiting lipids as an accessible carbon
source within the host.
In an early observation, isocitrate lyase (icl1) was shown to be
required for survival in macrophages and mice where the host
exhibited an intact immune response and was capable of acti-
vating the host cell (McKinney et al., 2000). ICL is the gating
enzyme into the glyoxylate cycle, which shunts carbon from
the Krebs cycle through to pyruvate, and possibly into gluconeo-
genesis. The glyoxylate cycle is required to retain carbon when
growing on fatty acids as the limiting carbon source. Recently,
however, a significant role for ICL1 and ICL2 during in vitro
culture and in vivo infection was shown to be the completion of
the 2-methylcitrate acid cycle (Munoz-Elias et al., 2006)
(Figure 4). The metabolism of cholesterol, methyl-branched fatty
acids and amino acids, and odd-chain-length fatty acids all lead
to the generation of the C3 product propionyl-CoA, which is toxic
to Mtb unless metabolized (Savvi et al., 2008). The 2-methylci-
trate cycle condenses propionyl-CoA with oxaloacetate to pro-
duce pyruvate and the Krebs cycle intermediate, succinate.
In the context of 2-methylcitrate acid cycle, ICL1 and ICL2Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 71
Figure 4. Outline of the Pathways Relevant
to C3 Metabolism
The metabolism of cholesterol, methyl-branched
fatty acids and odd-chain-length lipids will raise
the intracellular levels of the C3 compounds propi-
onate or propionyl-CoA, which Mtb finds highly
toxic. The bacterium has developed three different
strategies to detoxify propionyl-CoA. Isocitrate
lyase activity has been suborned to fulfill the func-
tion of methylcitrate lyase in the last step of the
methyl citrate cycle to generate the TCA cycle
intermediate succinate. The methylmalonyl path-
way has also been mobilized to metabolize
propionyl-CoA to produce succinyl-CoA via the
VitB12-dependent activity of methylmalonyl-CoA
mutase. Finally, intermediates from the methylma-
lonyl pathway can be incorporated directly into the
abundant, methyl-branched lipids of the bacterial
cell wall, such as PDIM and SL-1.
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Therefore an important function of ICL1/2 appears to be relieving
the toxicity caused by propionyl-CoA buildup.
The detoxification of propionyl-CoA pools seems absolutely
critical to Mtb, and the bacterium has also evolved to utilize
methylmalonyl-CoA intermediates to fulfill a similar function
(Figure 4). In Mtb, propionyl-CoA can be converted to methylma-
lonyl-CoA. The final step of the methylmalonyl pathway is the
conversion of methylmalonyl-CoA to succinyl-CoA, which is per-
formed by the VitB12-dependent enzyme methylmalonyl-CoA
mutase (MutAB) (Savvi et al., 2008). The methylmalonyl pathway
enables Mtb to grow on propionate in the presence of inhibitors
of ICL activity but requires supplementation of the medium with
VitB12 because methylmalonyl-CoA mutase, the final enzyme
of the methylmalonyl pathway, is a VitB12-dependent enzyme.
Additionally, methyl-branched fatty acids can be synthesized
directly from methylmalonyl-CoA precursors; thus, propionyl-
CoA products can be incorporated into cell wall lipids and
detoxified. Mtb produces many complex lipids containing
methyl-branched fatty acid side chains that are integral to the
Mtb cell wall (Jackson et al., 2007). Recently, it was shown
that Mtb grown on propionate as the limiting carbon source
exhibit enhanced synthesis of the virulence-associated methyl-
branched lipids sulfolipid (SL-1) and phthiocerol dimycocero-
sates (PDIM) (Jain et al., 2007). In addition, whenMtb was grown
on propionate or odd-chain fatty acids, the mycocerosic acids in
PDIM were extended by 3-carbons implying direct incorporation
of the methylmalonyl-CoA intermediate. Lastly, PDIM isolated
from mouse lung tissue displayed the same lengthened myco-
cerosic acids, suggesting that during the infection Mtb experi-
ences comparable buildup of propionyl-CoA (Jain et al., 2007).
These data argue strongly that Mtb needs to be able to process72 Cell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc.propionyl-CoA in vivo, where the carbon
source(s) remains to be defined.
While we do not have a full appreciation
of the carbon sources utilized by Mtb
during infection, there is genetic evidence
that Mtb mobilizes and metabolizes
cholesterol from the host (Pandey and
Sassetti, 2008). Mtb deficient in the cho-
lesterol transporter encoded by mce4(Mohn et al., 2008; Pandey and Sassetti, 2008) are able to
infect macrophages in vitro and mice in vivo; however, the
ability to express Mce4 is required to sustain the persistent
phase of the in vivo infection and for survival in IFN-g-activated
macrophages. These data are extremely similar to those
observed in icl1-deficient Mtb, suggesting that cholesterol is
metabolized by Mtb at certain phases during infection. It has
already been demonstrated that metabolism of cholesterol
contributes to the increase in the propionyl-CoA pool (Yang
et al., 2009).
A recent paper details a novel switching mechanism under
which Mtb can respond to redox fluctuations in the bacterial
cytosol by selectively incorporating propionate into the cell
wall lipids polyacyltrehalose (PAT), SL-1, PDIM, and triacylgly-
cerol (TAG) (Singh et al., 2009). This regulated utilization of propi-
onate was observed in murine macrophage infections in vitro
and was dictated by the transcriptional regulator WhiB3, which
functions by virtue of a thiol-disulfide redox switch. The WhiB3
mutant is resistant to propionate toxicity, which may be due
to the increased levels of PDIM produced by this mutant in
broth culture and within resting macrophages. Microarray anal-
ysis of Mtb in macrophages shows upregulation in expression
of WhiB3, as well as genes involved in the synthesis of PAT,
SL-1, and TAG (Rohde et al., 2007). Additionally, the generation
of energy from fatty acids through b-oxidation results in produc-
tion of NADH, which has the potential to disrupt redox homeo-
stasis. The authors went on to propose that in addition to
relieving propionate toxicity by direct incorporation ofmethylma-
lonyl-CoA precursers into lipids, any resulting redox imbalance
may also be remediated through the use of cell wall lipid
synthesis as a sink for reductants generated during lipid break-
down (Singh et al., 2009).
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The link between alterations in lipid metabolism of Mtb during
infection is also consistent with the physiological changes
observed in the host, at both the level of the macrophage and
the granuloma.
Infection of macrophages with Mtb or BCG in vitro causes the
induction of foam cell formation (D’Avila et al., 2006; Peyron
et al., 2008). Foam cells are the product of dysregulated lipid
metabolism whereby cholesterol is esterified and sequestered
in intracellular droplets that form in the ER and accumulate
within the cell cytosol. The induction of foam cell formation in
Mtb-infected macrophages is dependent on stimulation of TLR
receptors by Mtb cell wall lipids, predominantly oxygenated
mycolic acids present in trehalose dimycolate (TDM) (Bowdish
et al., 2009; D’Avila et al., 2006; Peyron et al., 2008).
Recently, we performed microarray analysis on human TB
granulomas following isolation by laser-capture microdissec-
tion (Kim et al., 2010). Among the genes most highly upregu-
lated were several encoding proteins involved in lipid process-
ing and sequestration, most notably the lipid droplet protein
adipophilin, ADFP. Immunohistology with antibodies against
these proteins demonstrated that they were highly expressed
in macrophages subtending the caseous center of the granu-
loma. Foamy macrophages can be extremely abundant within
TB granulomas and are thought to be the source of the
caseous debris that accumulates in the granuloma center.
We isolated the lipids of the caseum and employed thin-layer
chromatography and mass spectrometry to identify the major
lipid species as TAG, cholesterol, cholesterol ester, and lacto-
sylceramide. This lipid profile is consistent with the lipids of the
caseum being of host origin, and coming from low-denisty lipo-
protein-derived lipids that had been sequestered in foamy
macrophages (Kim et al., 2010; Russell et al., 2009a). These
data suggest that the generation of foam cells by Mtb could
represent a mechanism by which the pathogen could drive
the progression of the granuloma toward cavitation and
transmission.
Electron-microscopical analysis indicates that Mtb can gain
physical access to the lipid droplets within the cell, and it has
been postulated that this might be a privileged site that would
support growth of persistent bacteria within the granuloma
through the provision of nutrients and a host cell that is anergic
to activating cytokines (Peyron et al., 2008). Modeling this stage
of the progression has been problematic because fibrocaseous
granulomas are a feature of the human disease that is not gener-
ated effectively in mice. However, a recent report describes that
mice infected with Mtb and treated suboptimally with antibiotics
to kill replicating bacteria will reactivate and generate granu-
lomas more reminiscent of human caseous granulomas (Hunter
et al., 2007). Histopathology revealed focal lesions resembling
lipid pneumonia typified by alveoli filled with foamy macro-
phages. Acid-fast stain demonstrated that these foamy macro-
phages were the predominant cell type that harboredMtb bacilli.
In the central foci of necrosisMtb were observed associated with
lipid droplets. While these are only preliminary observations, this
study may provide a route for generating a murine granuloma
that more faithfully reproduces the physiological characteristics
of the human TB granuloma. Experimentally, this would be an
invaluable tool for understanding both the physiology of granu-loma progression and bacterial metabolism within this lipid-
laden tissue.Heterogeneity across the Infection
Histological examination of lung tissue from an individual with
active TB brings home an extremely significant problem to
understanding progression of disease from a persistent infection
to active TB. While an immunocompetent individual with active
disease will contain cavitated granulomas that spill infectious
bacteria into the airways, they are also likely to harbor granu-
lomas in all stages of ‘‘development’’ from containment through
to sterilized infection sites, as indicated from studies on higher
primates (Lin et al., 2009). It is unclear if there is any difference
between the systemic immune response in an individual harbor-
ing a controlled, persistent infection versus one with active
disease. Certainly programs attempting to identify systemic
biomarkers of disease state have met with extremely limited
success (Doherty et al., 2009; Wallis et al., 2009). While this
has serious implications for monitoring disease progress, or
understanding why one granuloma becomes active while others
resolve, it has even greater significance for vaccine development
because it implies that the best immune response leads to
nothing better than containment. To improve upon this, the
vaccine would have to exceed the effectiveness of the immune
response generated by a natural infection. To date, in animal
models, this has not been possible.
In addition to heterogeneity between different granulomas in
the same individual, there is also considerable heterogeneity
within the granuloma, which offers many different microenviron-
ments for Mtb. While it is proposed that Mtb replicates rapidly
and extracellularly upon cavitation of an active granuloma
(Kaplan et al., 2003), this has not been confirmed experimentally.
BecauseMtb is distributed in different sites within the granuloma
structure (Ulrichs and Kaufmann, 2006), it remains to be deter-
mined which regions are more permissive to bacteria growth
and which regions place the bacilli under greatest immune pres-
sure. These data are critical both for understanding drug action
and for the identification of new, more effective drug targets.
Existing drugs show preferential activity against replicating
bacteria, so if Mtb slows its replication rate or becomes
‘‘dormant’’ it will display an innate resistance to drug activity.
The presence of bacteria in different metabolic states likely plays
a major role in the need for prolonged treatment (6–9 months) to
effectively clear infection. New drugs that exploit targets relevant
to bacterial metabolism within the host are required; one such
example is the new ATP synthase inhibitors that impact both
growing and vegetative bacteria (Andries et al., 2005).Concluding Remarks
Tuberculosis represents a protracted discourse between both
host and pathogen that leads to extensive metabolic remodeling
in both organisms. The atherosclerotic-like host response within
the granuloma leads to lipid sequestration, which likely contrib-
utes to the pathology that culminates in cavitation and transmis-
sion. In turn, this realignment in host metabolism appears to
require alterations in Mtb that switches to the utilization of lipids
as alternate carbon sources. The metabolic interplay that is
emerging in the current literature seems to afford new insightsCell Host & Microbe 8, July 22, 2010 ª2010 Elsevier Inc. 73
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Reviewinto the pressure points in the life cycle of Mtb, which, hopefully,
will lead to new chemotherapeutic interventions.
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